Attached files
| file | filename |
|---|---|
| EX-23.2 - EXHIBIT 23.2 - Brooklyn ImmunoTherapeutics, Inc. | nt10023650x4_ex23-2.htm |
| EX-5.1 - EXHIBIT 5.1 - Brooklyn ImmunoTherapeutics, Inc. | nt10023650x4_ex5-1.htm |
| S-1 - S-1 - Brooklyn ImmunoTherapeutics, Inc. | nt10023650x4_s1.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-1 and related Prospectus of Brooklyn ImmunoTherapeutics, Inc. (formerly known as NTN Buzztime, Inc.) of our report
dated March 11, 2021, relating to the consolidated financial statements of NTN Buzztime, Inc. appearing in the Annual Report on Form 10-K of NTN Buzztime, Inc. for the year ended December 31, 2020 (which report expresses an unqualified opinion and
includes an explanatory paragraph relating to the Company’s ability to continue as a going concern).
We also consent to the reference to our firm under the heading “Experts” in such Prospectus.
/S/ BAKER TILLY US, LLP
San Diego, California
May 27, 2021